Evidence map›Paper›PMID 38617758›Full record

ArticleJournal of thoracic disease2024

Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry.

Sebastian Feickert, Niels Christian Ewertsen, Julia Köbe, Thomas Kleemann, Joachim Jehle, Jochen Senges, Matthias Hochadel, Dietrich Andresen, Christoph Stellbrink, Lars Eckardt and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Sebastian FeickertDepartment of Cardiology and Internal Intensive Care Unit, Berlin Heartrhythm Center, Vivantes Clinic Am Urban, Berlin, Germany.
Niels Christian EwertsenDepartment of Cardiology and Internal Intensive Care Unit, Berlin Heartrhythm Center, Vivantes Clinic Am Urban, Berlin, Germany.
Julia KöbeDepartment of Cardiology and Angiology, Division of Electrophysiology, University Hospital of Muenster, Muenster, Germany.
Thomas KleemannDepartment of Cardiology, Pneumology, Angiology and Internal ICU, Klinikum Ludwigshafen, Ludwigshafen, Germany.
Joachim JehleDepartment of Cardiology, Klinikum St. Elisabeth Straubing, Straubing, Germany.
Jochen SengesFoundation Institute for Myocardial Infarction Research, Ludwigshafen, Germany.
Matthias HochadelFoundation Institute for Myocardial Infarction Research, Ludwigshafen, Germany.
Dietrich AndresenHerzmedizin.berlin, Berlin, Germany.
Christoph StellbrinkDepartment of Cardiology, Klinikum Bielefeld, Bielefeld, Germany.
Lars EckardtDepartment of Cardiology and Angiology, Division of Electrophysiology, University Hospital of Muenster, Muenster, Germany.
Stefan SpitzerHeart and Vascular Practice Clinic, Dresden, Germany.
Johannes BrachmannDepartment of Cardiology, Klinikum Coburg, Coburg, Germany.
Hüseyin InceDepartment of Cardiology and Internal Intensive Care Unit, Berlin Heartrhythm Center, Vivantes Clinic Am Urban, Berlin, Germany.
Giuseppe D'AnconaDepartment of Cardiology and Internal Intensive Care Unit, Berlin Heartrhythm Center, Vivantes Clinic Am Urban, Berlin, Germany.
Berlin Heart (Germany) · DEUniversity Hospital Münster · DEUniversity of Rostock · DEVivantes Klinikum · DEBarmherzige Brüder Klinikum St. Elisabeth in Straubing · DEKlinikum Bielefeld · DEKlinikum Ludwigshafen · DESchmerzmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atrial fibrillation (AF) is a cardiac arrhythmia frequently documented in patients requiring implantable cardioverter defibrillators (ICDs) and/or cardiac resynchronization therapy with defibrillator (CRT-D). Patients with diagnosed AF at the point of ICD or CRT-D implantation may have an impaired follow-up outcome. Methods: The German DEVICE I-II registry is a nationwide prospective multicentre database of patients implanted with ICD and CRT-D with clinical follow-up data. We analysed a 1-year follow up of implanted patients with AF and with sinus rhythm (SR). Results: A total of 4,929 ICD/CRT patients are included in the present analysis: 946 (19.2%) were in AF and 3,983 (80.8%) were SR at time of device implantation. AF patients had a significantly more comorbid profile including older age {72 [interquartile range (IQR), 66-77] Conclusions: Our clinical data on an extended cohort of contemporary patients confirm the significant impact of AF, and its associated comorbidities, upon mortality and major adverse events after implantation of ICD/CRT.

Indexed as

atrial fibrillation (AF)cardiac resynchronization therapy with defibrillator (CRT-D)follow-upImplantable cardioverter defibrillators (ICDs)registry

Identifiers

PMID38617758
PMCPMC11009579
OpenAlexW4393299496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.